Objective: To compare the clinic, laboratory features, disease activity, the differences of treatment and effect of sero-nagative and sero-positive rheumatoid arthritis patients diagnosed by 2010 ACR/EULAR Classification Criteria for Rheumatoid Arthritis. Method: 297 RA patients were included in this study and allocated into sero-nagetive group(n=57)and sero-positive group(n=240). The clinic, laboratory features, disease activity, the differences of treatment and effect were compared between the two groups. Results: (1) The course of disease in sero-negative group was (47.58±26.43) months, the time required to diagnosis (33.71±21.56) months. The percentage of female patients in sero-negative group was 43%. (2) The total number of affected joints were 13.35±8.21, the affected small joints were 9.94±6.30; the percent of affected knees were 14.10%, the elbows were 18.73% and the ankles were 19.29%; but the affected metacarpophalangeal joints were 14.47%, the proximal interphalangeal joints were 15.21% and the wrists were 14.10%. (3) The percentage of the patients occurring interstitial lung disease were 21.05%, pulmonary hypertension were 17.54%, pericardial effusion were 5.3% in the sero-negative group. (4) Hb levels of the the sero-negative group were (108.28±16.94)g·L-1, PLT(284.87±91.51)×109 L-1, Glo(33.70±11.75)g·L-1, CRP(38.06±40.75)mg·L-1, ESR(58.63±38.76)mm·h-1. (5) As for the treatment, 46 patients in the sero-negative group chose glucocorticoids, 33 patients chose anti-osteoporosis drugs and 51 patients chose herbals. After treatment, the Glo level was decreased by(10.84±9.56)g·L-1, ESR decreased by(31.05±29.51)mm·h-1, CRP decreased by(28.85±35.87)mg·L-1 and DAS28 scores decreased by 1.79±1.00. Conclusion: Sero-negative RA patients can be diagnosed in the early course by 2010 ACR/EULAR classification criteria revision of RA. These patients are characterized by less involvements of joints and as well as less small joints, less complications, higher Hb levels and lower Glo, positive ESR and CRP levels and lower DAS28 scores. These patients can achieve better outcome than those in sero-positive group undergoing mild treatments. |
[1] KULDEEP S,PRACHI M.Anti CCP antibodies in the diagnosis and prognosis of rheumatoid arthritis[J].JK Science,2011,13(1):3-5.
[2] 耿研,张卓莉.血清学阴性与血清学阳性类风湿关节炎患者临床及免疫学特征的差异[J].中华临床免疫和变态反应杂志,2011,5(2):143-147.
[3] 刘永杰,范文娟.自身抗体阴性类风湿关节炎患者临床资料分析[J].中国药物与临床,2013,13(8):1079-1080.
[4] 陈仁利,苏茵,栗占国,等.自身抗体阴性类风湿关节炎的临床及实验室特点[J].中华风湿病学杂志,2007,11(8):466-468.
[5] 李鸿斌,铁宁,贾永峰,等.类风湿关节炎患者滑膜抗环瓜氨酸肽表位表达与Thl7/调节性T细胞的失衡和滑膜炎症的相关性分析[J].中华风湿病学杂志,2012,16(4):224-228.
[6] GENG Y,ZHANG Z L.Comparative study on the level of B lymphocyte stimulator(BlyS)and frequency of lymphocytes between sero-negative and sero-positive rheumatoid arthritis patients[J].Int J Rheum Dis,2012,15(5):478-485.
[7] HAYE SALINAS M J,RETAMOZO S,VETORAZZI L,et al.Anticitrulin antibody and the extra-articular manifestations in rheumatoid arthritis[J].Medicina,2013,73(1):21-25.
[8] KELLY C A,SARAVANAN V,NISAR M,et al.Rheumatoid arthritis-related interstitial lung disease:associations,prognostic factors and physiological and radiological characteristics-a large multicentre UK study[J].Rheumatology(Oxford),2014,53(9):1676-1682.
[9] YIN Y,LIANG D,ZHAO L,et al,Anti-cyclic citrullinated Peptide antibody is associated with interstitial lung disease in patients with rheumatoid arthritis[J].PLoS One,2014,9(4):e92449.
[10] GILES J T,DANOFF S K,SOKOLOVE J,et al.Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease[J].Ann Rheum Dis,2014,73(8):1487-1494.
[11] 冯贺,林翊萍.抗环瓜氨酸肽抗体与风湿性疾病相关性的研究进展[J].风湿病与关节炎,2014,3(11):79-80.
[12] 孙文文,朱芸,李明,等.类风湿关节炎合并肺间质病变的发病相关因素[J].临床肺科杂志,2013,18(5):860-961.
[13] 王亚黎,刘健,叶文芳,等.类风湿关节炎患者免疫球蛋白变化及相关因素分析[J].中国临床保健杂志,2014,17(2):116-117.
[14] 李雪飞,武加标,任敏,等.类风湿因子和抗环瓜酸抗体联合检测对类风湿关节炎的诊断价值及与疾病活动的相关性[J].现代医学,2011,39(1):59-61.
[15] 郭建萍,吴新宇,陆小兰,等,树突状细胞免疫受体基因多态性与抗环瓜氨酸肽抗体阴性类风湿关节炎相关性研究[J].中华风湿病学杂志,2012,16(1):4-8.
[16] CUI J,TAYLOR K E,LEE Y C,et al.The influence of polygenic risk scores on heritability of anti-CCP level in RA[J].Genes Immun,2014,15(2):107-114. |